Anthrocell

Anthrocell is an Australian biotechnology company focused on enhancing the clinical effectiveness and reducing the time to market of biopharmaceuticals. Their proprietary Anthrocell Expression System (ACX) produces fully human recombinant proteins derived from human immune system cells, aimed at improving health outcomes. The company is developing... a pipeline of monoclonal antibody products for breast cancer and offers bioservices as a contract research organization (CRO) to support clients in cell-line development and pre-clinical production. Anthrocell seeks to establish strategic alliances with companies developing novel biological products or enhancing existing ones.Read More